Dr Schuyler Cole Metlis, MD | |
6500 Hospital Dr, Hannibal, MO 63401-6890 | |
(573) 629-3500 | |
(573) 629-3515 |
Full Name | Dr Schuyler Cole Metlis |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 6500 Hospital Dr, Hannibal, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679546949 | NPI | - | NPPES |
039494700 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 2008030672 (Missouri) | Primary |
208200000X | Plastic Surgery | 036.126436 (Illinois) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Schuyler Cole Metlis, MD 6500 Hospital Dr, Hannibal, MO 63401-6890 Ph: (573) 629-3500 | Dr Schuyler Cole Metlis, MD 6500 Hospital Dr, Hannibal, MO 63401-6890 Ph: (573) 629-3500 |
News Archive
The fishing industry and some cultural practices in communities living around Africa's Lake Victoria are contributing to the spread of HIV/AIDS and other sexually transmitted infections in the area, according to a panel of experts at a recent meeting in Kisumu, Kenya, The Citizen reports.
If your chest pain worsens and lasts more than five minutes, especially if you're short of breath, feel weak, nauseated or lightheaded, call 9-1-1—you could be having a heart attack.
The health and well-being of Canadians could be greatly improved by adopting some of the environmental health approaches taken in Australia, Sweden and California, according to a Conference Board of Canada report, Critical Steps for Canada: Environmental Health Lessons Across Borders.
The Clinical Research Building (CRB), at the University of Miami Miller School of Medicine, has been honored for its sustainability components. The building was awarded the LEED- designation, established by the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED is the nation's preeminent program for the design, construction and operation of green buildings.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
› Verified 6 days ago